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ABSTRACT
The quality of the sublethal damage (SLD) after irradiation with high–linear energy transfer (LET) ion beams
was investigated with low-LET photons. Chinese hamster V79 cells and human squamous carcinoma SAS cells
were ﬁrst exposed to a priming dose of different ion beams at different LETs at the Heavy Ion Medical
Accelerator in the Chiba facility. The cells were kept at room temperature and then exposed to a secondary test
dose of X-rays. Based on the repair kinetics study, the surviving fraction of cells quickly increased with the repair
time, and reached a plateau in 2–3 h, even when cells had received priming monoenergetic high-LET beams or
spread-out Bragg peak beams as well as X-ray irradiation. The shapes of the cell survival curves from the second-
ary test X-rays, after repair of the damage caused by the high-LET irradiation, were similar to those obtained
from cells exposed to primary X-rays only. Complete SLD repairs were observed, even when the LET of the pri-
mary ion beams was very high. These results suggest that the SLD caused by high-LET irradiation was repaired
well, and likewise, the damage caused by the X-rays. In cells where the ion beam had made a direct hit in the
core region in an ion track, lethal damage to the domain was produced, resulting in cell death. On the other
hand, in domains that had received a glancing hit in the low-LET penumbra region, the SLD produced was com-
pletely repaired.
KEYWORDS: sublethal damage (SLD), high LET, direct hit, glancing hit, track structure
INTRODUCTION
The world’s ﬁrst heavy ion accelerator for therapy, the Heavy Ion
Medical Accelerator in Chiba (HIMAC), was constructed in the
National Institute of Radiological Sciences, Japan, in 1994. More
than 10 000 cancer patients have been treated since then, demon-
strating fruitful clinical results [1]. The most serious obstacle to
worldwide availability of carbon ion radiotherapy (CIRT) is the
high cost [2]. To reduce the cost, clinical and biological research
into hypofractionation schedules should be a high priority. CIRT is
optimized by dose escalation and hypofractionation, e.g. two frac-
tions in 2 days or single-fraction were applied in the treatment of
hepatocellular carcinoma or non-small-cell lung cancer. So-called
single-fraction CIRT at HIMAC [3] consists of a four-ﬁeld exposure
that takes 1–2 h in total, with several time intervals between the
exposures. The intervals allow repair and affect the clinical results.
In addition, it is generally believed that there is no damage repair, or
only slight damage repair, after high-LET irradiation. Radiobiological
knowledge about repair after high-LET particle irradiation could
reduce big dose escalation study in clinical use.
It is well known that cellular repair systems are very capable of
repairing DNA damage [4–6]. Radiation damage in cells can be
operationally divided into three categories [7]. (i) Lethal damage
(LD) refers to the irreparable and irreversible damage that leads to
cell death. (ii) Potentially lethal damage (PLD) refers to damage
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that can be modiﬁed by the post-irradiation microenvironment in
the cell, especially under suspended-growth conditions. Such dam-
age is lethal under ordinary conditions, but cells can survive when
the environment is well manipulated. (iii) Sublethal damage (SLD)
refers to reparable damage that allows survival within several hours
under the ordinary environmental conditions of cells; however, if
the cell is exposed to secondary radiation before repair of the dam-
age can be completed, then LD ensues. In general, the SLD gener-
ated by low-linear energy transfer (LET) irradiation is believed to
be better repaired than that caused by high-LET irradiation. SLD
repair can be found when cells are given a split dose with an interval
time for repair, known as split dose recovery. When the SLD has
been completely repaired before the secondary irradiation, the
radiobiological condition of the cells is the same as that of fresh and
healthy cells, except for those cells that have LD or PLD. Survival
curves with a shape analogous to that of healthy cells can be seen,
with a shift in the survival level of the curve according to the num-
ber of cells with LD and PLD. However, in the case of high-LET
irradiation, serious and complex cell damage is generated that is dif-
ﬁcult to repair, and the SLD may not be repaired well in those cells.
In this study, cells were exposed twice (after the ﬁrst and second
doses) to observe SLD. After the ﬁrst irradiation, cells were allowed
a certain repair time before being exposed to the second irradiation.
A point to note is that the ﬁrst priming dose was with ion beams at
different high-LETs, whereas the second test doses were all of X-
rays. SLD repair is difﬁcult to observe when cells are exposed to
high-LET irradiation as the second test dose, because the survival
curve from such irradiation has a small shoulder [8]. It is commonly
accepted that SLD repair is only slightly observable, if at all, when
high-LET radiation is used. In this study, we revealed that SLD
repair occurs after priming irradiation with high-LET ion beams,
and this can be seen when using X-rays as a test radiation.
MATERIALS AND METHODS
Cells
Chinese hamster V79 cells and human squamous carcinoma SAS
cells (Cat. No. JCRB0260; Japanese Collection of Research
Bioresources (JCRB) Cell Bank, Osaka, Japan) were cultured in
Ham’s F-12 medium (Gibco BRL, Tokyo, Japan), supplemented
with 10% fetal bovine serum and antibiotics (100 U/ml penicillin
and 100 μg/ml streptomycin), at 37°C in a 5% CO2 incubator.
Cells at the exponential growth phase were harvested with 0.2%
trypsin, split and diluted in the medium, and seeded at a density of
2.5 × 105 cells in a T25 ﬂask every 2–3 days for V79 cells or every
5–6 days for the SAS cells. At 1 day prior to irradiation, the har-
vested cells were seeded in T25 or T12.5 ﬂasks at 2.5 × 105 or
1.5 × 105 cells with 5 or 3 ml of the medium, respectively.
Radiation treatments
Two X-ray generators were used in this experiment, both having a tung-
sten target, equipped with a 0.5 mm Al and 0.5 mm Cu ﬁlter, and oper-
ated at 20mA with 150 or 200 kVp. The generator operating at
150 kVp was installed in the biology cave of the Heavy Ion Medical
Accelerator in Chiba (HIMAC; National Institute of Radiological
Sciences, Chiba, Japan), and it was used for the SLD repair time kinetics
study. The other generator, operating at 200 kVp, was installed in the
X-ray facility building, and it was used for the fractionated secondary
irradiations in the survival curve study. The dose rate was ~1Gy/min.
We used 290MeV/u carbon (dose-averaged LET at 13, and
100 keV/μm on the sample), 490 MeV/u silicon (55 keV/μm),
500 MeV/u argon (85 keV/μm), 500 MeV/u iron (200 keV/μm)
and 200 MeV/u iron (440 and 860 keV/μm) beams, accelerated by
HIMAC, as high-LET ion beams. Excess energy reducers that were
made from polymethyl methacrylate (PMMA) were inserted upstream
of the sample to obtain 100 or 860 keV/μm beams. We also used
290MeV/u carbon beams with a 6 cm spread-out Bragg peak
(SOBP) at the centre (50 keV/μm) [9, 10]. Those beams were deliv-
ered to the biology cave in HIMAC, and the radiation ﬁeld was
expanded with a scatterer and wobbler to a 10 cm diameter within 5%
of dose uniformity. The radiation doses were monitored by a monitor-
ing ionization chamber placed upstream of the sample. The output of
the monitor chamber was proofed by a calibrated ionization chamber
placed at the sample position. The radiation doses were controlled
with the accumulated output readings of the monitor chamber.
The priming doses chosen were based on an approximate one-
tenth reduction of cell survival for each beam. The test doses for the
repair kinetics study were also chosen to reduce cell survival by
another one-tenth, meaning that when the total dose was given with-
out repair time, the expected total cell survival was one-hundredth.
Repair-time kinetics
For the kinetics study of SLD repair, V79 and SAS cells were again
employed. Cells of each type were lined up on an automatic irradi-
ation table at HIMAC. The temperature of the room was controlled
at 25°C. All cell samples in each experimental group were exposed
to the same beam at a 10% survival dose. After exposure of the
priming dose, the cells were kept at room temperature for
180–600 min until the test doses of X-ray or SOBP beam were
applied. The maximum repair time was limited by the machine
schedule. The time between completion of the priming dose and
initiation of the test radiation was deﬁned as the repair time.
Immediately after the test dose, the cells were collected by tryp-
sinization (0.2%) and resuspended in the medium. Adequately diluted
cells of ~100 live cells were seeded in triplicates in each 6 cm dish
with 5 ml of the medium and then incubated for 6 days (for V79
cells) or 13 days (for SAS cells). Cells from the resulting colonies
were ﬁxed with 10% formalin solution and stained with 1% methylene
blue, and colonies consisting of more than 50 cells were counted as
survivors in order to determine the surviving fraction (SF).
Survival curve parameters
For the survival curve parameter study, only V79 cells were used.
The cell samples were sequentially irradiated with a deﬁned LET
beam at different doses for acute single-shot survival. Cell samples
of the pairing group for split doses were exposed to a priming dose
of each beam that was expected to allow ~10% survival. The sam-
ples were kept at 25°C for 3–4 h (limited by HIMAC and X-ray
machine schedules) to allow repair, and then subjected to test X-
rays (200 kVp) of different doses. Immediately after the test dose,
the colony-forming assay was performed as described above.
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All survival data were normalized to the 0 Gy sample for the
acute single shot for each LET group. The SF data were ﬁtted with
the modiﬁed linear–quadratic (LQ) equation (1), and the multi-
target model equation (2) from the target theory as follows [11]:
δ α β= ⋅ (− ⋅ − ⋅ ) ( )SF D Dexp 12
= − [ − ( )] ( )SF D D1 1 exp / 20 n
where SF and D are the survival fraction of cells and the dose, α and β
are the parameters of the curve, as in as their deﬁnition in the LQ mod-
el, and parameter δ is the survival shift value between the priming and
test irradiations. For analysis of the data for an acute single shot experi-
ments, δ was set as 1 (because cell survival was not shifted according to
the priming radiation). Coefﬁcients D0 and n stand on mean lethal dose
and extrapolation number in the multi-target model. The curves were
ﬁtted, and the parameters were obtained by a computer program with a
least-square method. The D10 values were calculated from α and β.
RESULTS
Time kinetics of repair
The repair kinetics of cell survival were observed as a function of
repair time. A time-dependent increase in SF was clearly observed
for all cases (Fig. 1). We could see the repair in hamster cells (V79)
after use of monoenergetic high-LET beams or X-rays as the prim-
ing dose, with X-rays as the secondary dose. This was also seen in
the human cells (SAS) after both priming and secondary doses with
the therapeutic carbon SOBP beam. The dose-averaged LET of the
SOBP beam, and monoenergetic carbon, iron and X-ray beams
were 50, 440, 100 and 9.4 keV/μm, respectively [12].
Irradiated cells were quickly repaired from SLD at room temperature,
showing peaks at 50min of repair. An unexpected dip in survival was
found at 60min for all cases. The cell survival was ~2.5 times higher after
180min than that at time zero. The highest increase in the SF in V79
cells treated with 100 keV/μm carbon plus X-rays was found at 600min.
Survival curve parameters
Figure 2 shows the dose–response curves of V79 cells after treatment
with reference X-rays (black), an acute single shot of each high-LET
radiation (red), and test X-ray doses after the priming dose and repair
time (green). Plots in black indicate the average and standard deviation
(SD) from ﬁve independent experiments (as reference survival data)
with the 200 kVp X-ray beam (Fig. 2A). All the other data, except for
the reference X-rays, were produced from a single experiment. The
same curves (black lines) were added to all the other panels as the ref-
erence. In this experiment, cells were exposed ﬁrst to different radia-
tions and then to 200 kVp X-rays as the test radiation following the
repair time, to express the SLD repair. The horizontal axis indicates
the acute single-shot dose for each radiation, or the test X-ray dose.
The curves (red) became steeper with the increase of LET up to
100 or 200 keV/μm, and then decreased with the high-LET beams.
Survival curves (green) with shapes analogous to those of the refer-
ence X-ray curve were found, with a shift in the plating efﬁciency.
The numerical parameters (α, β, D0 and D10) of the curves in
Fig. 2 are listed in Table 1. The α and β values (mean ± SD, from
ﬁve independent experiments) for the acute single shot (top right in
Table 1) were 0.192 ± 0.029 Gy−1 and 0.0176 ± 0.0027 Gy−2,
respectively. Clear differences of α and β values after an acute single
shot with different LET beams were found between the groups. The
α values increased with increase in the LET, showing maxima at 100
or 200 keV/μm, and then decreased with higher LETs. However, no
clear differences were found in the parameter values for the test X-
rays. The values varied in a limited range around those for the refer-
ence X-rays. The averaged values of α, β, D0 and D10 were
0.177 ± 0.020 Gy−1, 0.0184 ± 0.0034 Gy−2, 2.95 ± 0.17 Gy and
7.38 ± 0.24 Gy, respectively, for the test X-rays, showing only a slight
discrepancy with respect to the reference X-ray data (0.192 ± 0.029 Gy−1,
0.0176 ± 0.0027 Gy−2, 2.62 ± 0.22 Gy and 7.23 ± 0.49 Gy, respect-
ively). Upon hypothesis and testing of the difference of the means,
by X-rays and that by acute single shot experiments, the hypothesis was
rejected by Student’s t-test, with P values of 0.235, 0.635, 0.279 and
0.426, respectively. The test of equivalency was difﬁcult to perform.
DISCUSSION
The quick process of SLD repair must be taken into consideration
in treatment planning for heavy-ion radiotherapy. We found clear
time-dependent repair kinetics (Fig. 1, upper panel) of human cells
Fig. 1. Repair–time kinetics of the cell survival fraction
after split dose irradiation. Upper panel: SAS cells
irradiated with both primary and secondary radiations
of 290 MeV/u carbon with 6 cm SOBP beams at the
middle position, with an interval time. Lower panel:
V79 cells irradiated with monoenergetic iron ions at
440 keV/μm, carbon ions at 100 keV/μm, or 150 kVp
X-ray beams as the priming radiation, with an interval
time, followed by secondary 150 keV X-rays. The dose
for primary irradiation was selected to give a 10%
survival rate, and that for secondary irradiation was
selected to give another 10% survival at an interval time
of zero (i.e. 1% survival in total). The cells were kept at
different times (t) at 25°C for repair.
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after the use of SOBP beams for cancer therapy at HIMAC. In the
case of cell viability, the SF was 0.012 after 5.5 Gy (=3.7 + 1.8)
SOBP beam irradiation without intervals, increased to 0.02 at
20 min, and reached nearly 0.03 after 180min. This quick increase in
cell survival must affect the treatment results. The multiﬁeld method
is applied for CIRT at HIMAC. The so-called single-fraction CIRT
of lung cancer [3] consists of a four-ﬁeld exposure, which takes time
intervals between exposures. This consideration was, however, not
taken into account in treatment planning at ﬁrst, and a dose escal-
ation study was performed instead to determine the treatment proto-
col. It was started with the relative biological effectiveness (RBE)
dose of 28 Gy in 2003 and reached 50 Gy (RBE) in 2011. Similar
kinetics (Fig. 1, lower panel) were also found in V79 cells, using
monoenergetic 100 or 440 keV/μm high-LET beams or X-rays. In
this case, the 150 kVp X-ray machine installed in the biology cave
was employed for the secondary irradiation in order to obtain data
with short intervals. A clear incremental increase in survival with
increase in repair time was found for all cases at approximately 3 h,
and survival reached three times higher than that without the inter-
val. Repair of SLD existed even after high-LET irradiation, as demon-
strated by Dr Ngo using neutrons or neon ions [13, 14].
When the same ion beams were used for both the priming and
test irradiations, the dose–response curves were different from those
with the LET beams, and they became linear at high-LETs, making
it difﬁcult to compare the efﬁciency of SLD repair between different
LET beams. To test the repair efﬁciency after high-LET irradiations,
we employed the same 200 kVp X-rays as the test radiation through-
out the experiments. A similar method was used for a SLD experi-
ment with fast neutrons [13]. Cells with LD will be killed by the
priming dose and the SF will not be affected by the test dose. The
SLD caused by the priming high-LET radiations will be well
repaired during the interval, and the cells recover to become healthy
cells. The shapes of the survival curves from the test X-rays must be
analogous to one another and to that of the reference X-rays. It is
generally believed that there is no damage repair, or only slight
damage repair for high-LET radiations. However, efﬁcient SLD
repair was found after high-LET irradiations as X-rays in this experi-
ment, even when the LET of the primary radiation was very high.
SLD repair kinetics have been determined by Elkind and Sutton
[15] in V79 cells cultured under 37°C. A quick increase in the SF
was observed within 1 h after X-ray exposure; it then showed a
slight decrease at around several hours after the primary exposure,
due to accumulation of cells at the radiosensitive cell cycle phase.
This decrease at several hours after priming irradiation was not
observed at 24°C [16]. The efﬁciency and the speed of the repair
are slightly lower under room temperature than at 37°C; however,
clear repair is observed at temperatures under 24°C [16] (and even
at temperatures under 3°C). The repair kinetics in our experiments
showed a small dip in the SF at 60 min for all cases. The time
points for the former experiments were too coarse to detect this
Fig. 2. Survival curves of V79 cells after irradiation with single (black or red) or split (green) doses. Ions and dose-averaged
linear energy transfer (LET) values (keV/μm) for each primary radiation with the doses are indicated in the graph keys. All
secondary doses given were from 200 kVp X-rays. Cells were kept at room temperature (25°C) during the irradiations and
repair interval times (see Table 1). A) Reference single-shot survival curve (mean ± SD) for 200 kVp X-rays from ﬁve
independent experiments; the same curve (black lines) is inserted in all the other panels. B—H) Red curves indicate results
from the high-LET single-dose experiments on healthy cells (PE = 85–95%). Green curves are the secondary X-ray survival
curves after repair from the split dose experiments; the PE of non-irradiated cells was normalized to a value of 1.
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quick, small dip in cell survival. Because we scheduled much denser
time points (i.e. 0, 10, 20, 30, 45, 60 and 120 min), this dip could
be observed. We had thought that the cells may have accumulated
in the sensitive phase to cause the dip, but evidence for this was not
found by ﬂow cytometry analysis (data not shown). If the pool size
of some important DNA damage repair–related proteins gets
reduced as a result of their concentration in the lesion by the prim-
ing dose, it may make repair of the damage produced by the test
dose difﬁcult. In one study [17], a part of cell nuclei in HeLa cells
were irradiated at two separate times with a microbeam, and the cell
nuclei at the earlier and later irradiated sites were immunostained.
The ﬂuorescent intensity of 53BP1 and Rad51 in the later irradiated
site (at 50 min after the earlier irradiation) decreased to <50% of
that in the earlier irradiated site, but no clear increase after 50 min
was observed. On the other hand, the intensity of gH2-AX was not
different before and after irradiation.
The data in green plots in Fig. 2 show the survival curves after test
X-rays following priming with high-LET radiations and a repair inter-
val. The survival curves were analogous to the reference X-rays for all
cases. All numerical survival parameters after the repair interval
showed similar values to those of the reference X-ray curve (Table 1).
The α, β, D0 and D10 values after the test X-rays were randomly
spread in the range of 0.142–0.208 Gy−1, 0.0131–0.0245 Gy−2,
2.73–3.31 Gy and 7.08–7.96 Gy, respectively, and the respective aver-
aged values for the reference X-rays were 0.192 ± 0.029 Gy−1,
0.0176 ± 0.0027 Gy−2, 2.62 ± 0.22 Gy and 7.23 ± 0.49 Gy. We could
see no clear differences in these parameters for the test X-rays, even
when the LETs of the priming radiations were different. Thus, we
ignored the quality of the primary radiations, and calculated the aver-
age values of those parameters for the test X-rays (Table 1). The aver-
age values showed no signiﬁcant differences to those for the reference
X-rays.
The ion beam–mediated DNA lesion produced in a cell can be
divided into two types: those from a ‘direct hit’ and those from a ‘glan-
cing hit’. Ion beams have unique track structures; for example, the so-
called ‘core’ and ‘penumbra’ having high and low ionization density
parts around one ion traversal, respectively. We also considered the
presence of a ‘domain’ (i.e. a small target volume of sub-micrometer
size in a cell nucleus, such as is deﬁned in the microdosimetric kinetic
(MK) model [18, 19], which has an important role in the killing of
cells. LD (including PLD) will be produced by a direct hit on the
domain at the core, whereas SLD will be produced by a glancing hit
on the domain at the penumbra. This may be similar to the γ-kill and
ion-kill theory [20]. LD causes cell killing after priming irradiation and
will not inﬂuence the survival from the test irradiation, except for
down-shifting of the curve. SLD is produced by glancing hits, where
the LET is low and the dose will be given by δ-rays. This lesion gener-
ated by δ-rays must be the same as that caused by low-LET photons
and is repaired as completely as the lesions from X-rays. Our results
suggest that complete repair of SLD occurs even after high-LET
Table 1. Survival curve parameters for V79 cells
Priming radiation Parameters to test X-ray Parameters to Single acute shot
Ion & Energy
(MeV/u)
LETa
(keV/μm)
Dose
(Gy)
δb α
(Gy−1)
β
(Gy−2)
D0
(Gy)
D10
(Gy)
Interval
(h)
α
(Gy−1)
β
(Gy−2)
D0
(Gy)
D10
(Gy)
Reference (X-ray 200 kVp) mean 0.192 0.0176 2.62 7.23
(n = 5) sd 0.029 0.0027 0.22 0.49
X-ray (200 kVp) 8.0 0.072 0.182 0.0171 3.04 7.45 3.2 0.232 0.0147 2.56 6.90
C-290 13 6.8 0.068 0.197 0.0172 2.83 7.19 3.0 0.199 0.0267 2.12 6.28
Si-490 55 3.0 0.105 0.195 0.0161 3.00 7.35 3.0 0.521 0.0404 1.37 3.48
Ar-500 85 2.5 0.113 0.184 0.0163 3.03 7.50 3.0 0.620 0.0506 1.16 2.98
Ar-500 85 3.0 0.066 0.173 0.0193 2.93 7.33 3.0 0.593 0.0712 1.05 2.88
C-290 100 2.5 0.102 0.152 0.0245 2.73 7.08 3.0 0.800 0.0261 1.07 2.65
C-290 100 2.0 0.129 0.142 0.0241 2.80 7.26 4.0 0.823 0.0259 1.09 2.59
Fe-500 200 1.75 0.189 0.153 0.0171 3.31 7.96 4.0 0.822 0.0483 0.98 2.45
Fe-200 440 3.5 0.078 0.177 0.0183 2.89 7.37 4.0 0.612 0.0273 1.32 3.28
Fe-200 440 3.5 0.071 0.182 0.0198 2.78 7.13 4.0 - - - -
Fe-200 860 3.5 0.090 0.208 0.0131 3.14 7.51 3.0 0.398 0.0193 1.88 4.71
mean 0.098 0.177 0.0184 2.95 7.38
sd 0.037 0.020 0.0034 0.17 0.24
aDose averaged LET. bShift value of survival curve at 0 Gy.
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radiation exposure. In conclusion, a lesion of SLD is produced by glan-
cing hit of a domain in a cell nucleus with an ion beam at a low-LET
component in the track. The quality of the lesions that are caused by
an ion beam must be the same to that caused by X-rays.
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